There is increasing evidence suggests that insulin resistance has crucial role in AD pathogenesis, probably due to high GSK3β activation causing intra and extracellular amyloid-Beta (Aβ) accumulation and tau phosphorylation [5–7]. The gene discussed is MAPT; the disease is Alzheimer disease.